On June 12, 2019, the International Myeloma Foundation’s Advocacy department led a group of cancer advocates to Capitol Hill as a part of Coalition to Improve Access to Cancer Care (CIACC) efforts to increase support for the Cancer Drug Parity Act of 2019.
The advocates met with Congressional Members and their staff to ask for their support of the Cancer Drug Parity Act of 2019. The bipartisan bill corrects a disparity in insurance benefit design for commercial plans. Patients on oral or self-administered anticancer medication face more expensive cost-sharing than those on traditional IV therapies. Yet, the costs for both types of treatments are relatively the same to insurance companies. This bill could greatly help myeloma patients on oral chemotherapy medications. It would reduce those patients' out-of-pocket costs for their drugs.
The IMF’s Senior Director of Public Policy & Advocacy spoke positively of the Congressional visits. “Our Day on Capitol Hill was incredibly successful and we were able to visit over 30 different offices in a single day. The IMF will continue to educate lawmakers to gain supporters, but we need the help of the myeloma community to move the bill forward.”
To help in our efforts, the IMF asks for your assistance to amplify our efforts during our Hill day. Send a message to Congress about your support for this legislation now.